Scientific Advisory Board

 

Helen M. Burt, PhD, CAHS, OC

Angiotech professor (retired) of drug delivery in the UBC Faculty of Pharmaceutical Sciences. Her major research efforts involve the development of polymer-based drug delivery systems for controlled and localized drug delivery. Dr. Helen Burt was the director of research for Angiotech Pharmaceuticals Inc and was a founding scientist and a member of the Executive Board of Directors of the Centre for Drug Research and Development (CDRD).

 

Howard Feldman, MD, FRCP (C)

Professor at the University of California, San Diego; Vice President and Therapeutic Area Head, Global Clinical Research, Neuroscience, Bristol-Myers Squibb (2009-2011); led a number of international clinical trials for major pharma companies, such as GSK, Pfizer, Lilly, Janssen, Sanofi, Novartis, Boehringer Ingelheim, Bayer and Roche.

 

John Cairns, MD, FRCPC, FRCP (Lond.), FCAHS, FACC

Professor of Medicine (retired) in the UBC Division of Cardiology. He has been a principal investigator of multiple clinical trials for major pharma companies, such as AstraZeneca, Sanofi and Genentech, has led or participated in the development of clinical practice guidelines in Canada and North America for treatment and prevention of various cardiac conditions, and has chaired or been a member of steering committees for numerous major cardiovascular clinical trials.